These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 28007570)

  • 81. Oleoylethanolamide, a natural ligand for PPAR-alpha, inhibits insulin receptor signalling in HTC rat hepatoma cells.
    Martínez de Ubago M; García-Oya I; Pérez-Pérez A; Canfrán-Duque A; Quintana-Portillo R; Rodríguez de Fonseca F; González-Yanes C; Sánchez-Margalet V
    Biochim Biophys Acta; 2009 Aug; 1791(8):740-5. PubMed ID: 19345745
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Immunomodulatory effect of oleoylethanolamide in dendritic cells via TRPV1/AMPK activation.
    Yao E; Zhang G; Huang J; Yang X; Peng L; Huang X; Luo X; Ren J; Huang R; Yang L; Zhou Y; Zhuo R; Zhao Y; Jin X
    J Cell Physiol; 2019 Aug; 234(10):18392-18407. PubMed ID: 30895621
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Evaluation of Prader-Willi Syndrome gene MAGEL2 in severe childhood-onset obesity.
    O'Neill MA; Farooqi IS; Wevrick R
    Obes Res; 2005 Oct; 13(10):1841-2. PubMed ID: 16286533
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Impaired hypothalamic regulation of endocrine function and delayed counterregulatory response to hypoglycemia in Magel2-null mice.
    Tennese AA; Wevrick R
    Endocrinology; 2011 Mar; 152(3):967-78. PubMed ID: 21248145
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Modulation of meal pattern in the rat by the anorexic lipid mediator oleoylethanolamide.
    Gaetani S; Oveisi F; Piomelli D
    Neuropsychopharmacology; 2003 Jul; 28(7):1311-6. PubMed ID: 12700681
    [TBL] [Abstract][Full Text] [Related]  

  • 86. A single postnatal injection of oxytocin rescues the lethal feeding behaviour in mouse newborns deficient for the imprinted Magel2 gene.
    Schaller F; Watrin F; Sturny R; Massacrier A; Szepetowski P; Muscatelli F
    Hum Mol Genet; 2010 Dec; 19(24):4895-905. PubMed ID: 20876615
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Effects of a single dose of exenatide on appetite, gut hormones, and glucose homeostasis in adults with Prader-Willi syndrome.
    Sze L; Purtell L; Jenkins A; Loughnan G; Smith E; Herzog H; Sainsbury A; Steinbeck K; Campbell LV; Viardot A
    J Clin Endocrinol Metab; 2011 Aug; 96(8):E1314-9. PubMed ID: 21632815
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Prader-Willi syndrome: From genetics to behaviour, with special focus on appetite treatments.
    Griggs JL; Sinnayah P; Mathai ML
    Neurosci Biobehav Rev; 2015 Dec; 59():155-72. PubMed ID: 26475993
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [The endocannabinoid system and food intake control].
    Rodríguez de Fonseca F
    Rev Med Univ Navarra; 2004; 48(2):18-23. PubMed ID: 15382609
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Satiety Factors Oleoylethanolamide, Stearoylethanolamide, and Palmitoylethanolamide in Mother's Milk Are Strongly Associated with Infant Weight at Four Months of Age-Data from the Odense Child Cohort.
    Bruun S; Gouveia-Figueira S; Domellöf M; Husby S; Neergaard Jacobsen L; Michaelsen KF; Fowler CJ; Zachariassen G
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30428553
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Disentangling ingestive behavior-related phenotypes in Prader-Willi syndrome: Integrating information from nonclinical studies and clinical trials to better understand the pathophysiology of hyperphagia and obesity.
    Wevrick R
    Physiol Behav; 2020 May; 219():112864. PubMed ID: 32156555
    [TBL] [Abstract][Full Text] [Related]  

  • 92. SnoRNA Snord116 (Pwcr1/MBII-85) deletion causes growth deficiency and hyperphagia in mice.
    Ding F; Li HH; Zhang S; Solomon NM; Camper SA; Cohen P; Francke U
    PLoS One; 2008 Mar; 3(3):e1709. PubMed ID: 18320030
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Peripheral endocannabinoid signaling controls hyperphagia in western diet-induced obesity.
    Argueta DA; DiPatrizio NV
    Physiol Behav; 2017 Mar; 171():32-39. PubMed ID: 28065722
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Mast Cell-Derived Histamine Regulates Liver Ketogenesis via Oleoylethanolamide Signaling.
    Misto A; Provensi G; Vozella V; Passani MB; Piomelli D
    Cell Metab; 2019 Jan; 29(1):91-102.e5. PubMed ID: 30318340
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Effect of oleoylethanolamide on diet-induced nonalcoholic fatty liver in rats.
    Li L; Li L; Chen L; Lin X; Xu Y; Ren J; Fu J; Qiu Y
    J Pharmacol Sci; 2015 Mar; 127(3):244-50. PubMed ID: 25837920
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Measurement of excessive appetite and metabolic changes in Prader-Willi syndrome.
    Holland AJ; Treasure J; Coskeran P; Dallow J; Milton N; Hillhouse E
    Int J Obes Relat Metab Disord; 1993 Sep; 17(9):527-32. PubMed ID: 8220655
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Inhibitory effect of the anorexic compound oleoylethanolamide on gastric emptying in control and overweight mice.
    Aviello G; Matias I; Capasso R; Petrosino S; Borrelli F; Orlando P; Romano B; Capasso F; Di Marzo V; Izzo AA
    J Mol Med (Berl); 2008 Apr; 86(4):413-22. PubMed ID: 18278475
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The cannabinoid CB1 receptor antagonist SR141716A (Rimonabant) enhances the metabolic benefits of long-term treatment with oleoylethanolamide in Zucker rats.
    Serrano A; Del Arco I; Javier Pavón F; Macías M; Perez-Valero V; Rodríguez de Fonseca F
    Neuropharmacology; 2008 Jan; 54(1):226-34. PubMed ID: 17467748
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Oleoylethanolamide dose-dependently attenuates cocaine-induced behaviours through a PPARα receptor-independent mechanism.
    Bilbao A; Blanco E; Luque-Rojas MJ; Suárez J; Palomino A; Vida M; Araos P; Bermúdez-Silva FJ; Fernández-Espejo E; Spanagel R; Rodríguez de Fonseca F
    Addict Biol; 2013 Jan; 18(1):78-87. PubMed ID: 23163925
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Intestinal NAPE-PLD contributes to short-term regulation of food intake via gut-to-brain axis.
    Rastelli M; Van Hul M; Terrasi R; Lefort C; Régnier M; Beiroa D; Delzenne NM; Everard A; Nogueiras R; Luquet S; Muccioli GG; Cani PD
    Am J Physiol Endocrinol Metab; 2020 Sep; 319(3):E647-E657. PubMed ID: 32776827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.